Layers
Health care
Health care, including the services and products used to provide care. Its monetary output is a measure of economic production. Improvements in health also depend on the effectiveness and distribution of that care.
What-if model · Chosen targets, conditional projections and calculated gaps.
- Estimate todayToday · 2026$23.5TStarting estimate
- Conditional projectionOn course · 2035$30.0T$6.5T projected growth
- Historical-benchmark comparisonBaseline + tier 1$31.8T$1.8T tier 1 gap
- Chosen scenarioChosen 2035 target$51.1T$19.3T tier 2 gap
Annual output at 2026 purchasing-power prices. The historical-benchmark comparison includes input adjustments and is limited to the portion used for this target; it is not a physical ceiling.
Where the map's three numbers come from
These amounts belong to health care alone. The first is projected growth under the baseline assumptions. The other two are calculated gaps to a chosen target. They do not predict how much new output will actually arrive.
| Part | Calculation | Amount |
|---|---|---|
| Baseline growth | $30.0T − $23.5T | $6.5T |
| Tier 1 gap | $31.8T − $30.0T | $1.8T |
| Tier 2 gap | $51.1T − $31.8T | $19.3T |
Display values are rounded. The underlying calculation uses the full precision in the CSV.
Why is this the sector target?
The model first chooses a $448.5T world economy, then chooses what that economy contains. This layer receives 11.4% of that total: $51.1T.
The allocation uses a spending-response factor of 1.280, estimated from historical household-spending data. In plain English, a 1% income increase is associated with roughly 1.28% more spending on this category in that relationship. Applying it to a future doubled world is a modelling choice.
The calculation combines a macro baseline allocated at today's sector shares with an additional gap allocated using those response factors. It then scales all sector targets to the same world total. A different allocation rule gives different sector targets and tier gaps.
Source files · inputs/stage1-v3/requirements/target_economy.csv · inputs/stage1-v3/requirements/code/model.py · inputs/stage1-v3/requirements/report.md
Compare two target choices already in the source
| Target mix | This sector's target | Its tier 2 gap |
|---|---|---|
| Selected spending mix | $51.1T | $19.3T |
| Every sector simply doubles | $46.9T | $15.2T |
Both choices allocate the same total world target. This is the upstream v3 comparison that v4 inherits for its sector targets; it is not a new run of the v4 shortage model or a probability range.
Source files · inputs/stage1-v3/requirements/layers_v3.csv
Show the calculation
Today + on-course growth + tier 1 + tier 2 = target
$23.5T + $6.5T + $1.8T + $19.3T = $51.1T
Display values are rounded. The CSV retains the precision used in the checks. Each term carries its own evidence label.
| Component | Amount | Evidence |
|---|---|---|
| today | $23.5T | [E] Estimated |
| growth | $6.5T | [A] Assumed |
| tier1 | $1.8T | [A] Assumed |
| tier2 | $19.3T | [A] Assumed |
| target | $51.1T | [E] Estimated |
What constrains this chosen scenario?
Each row below calculates a constraint if this target mix is attempted. It is not a forecast of lost GDP. Each test treats the other inputs as available, so the amounts overlap. The model credits the largest individual block within each tier when calculating explained output.
| Shortage | Blocked in this layer | Evidence |
|---|---|---|
| Clinical approval | $19.6T | [E] Estimated |
| Professional licensing | $13.8T | [A] Assumed |
| Part of the gap | Missing | Largest shortage explains | Unexplained |
|---|---|---|---|
| Tier 1 | $1.8T | $1.3T | $437bn |
| Tier 2 | $19.3T | $18.3T | $1.0T |
Read the model's explanation for each tier
Clinical approval on course meets 60% of need; at its fastest precedent (Further health output is workforce (2010-19) and productivity (2015-24) precedents achieve) it meets 64%: on course it grows at its trend, not its record pace. Buyers (repaired baseline demand test at the max-output income): demand at today's price exceeds max output
Clinical approval would have to grow 9.0% a year 2026-35 against 3.8% at its fastest precedent (2.4x faster)
Would the extra output be bought?
At its assumed 2035 price, the model estimates demand of $57.0T against a target of $51.1T. The buyer shortfall is $0bn.
See the demand calculationSources and exact values
Source files · layers_v4.csv · rows_v4.csv · own_blocks_v4.csv
stage1-v3/requirements/layers_v3.csv; stage1-v3/repair/baseline/layers.csv (today)